Cerus Corp

CERS remains in a Stage 2 advancing uptrend, preserving higher highs above the rising 50 DMA. However, recent rejection at the 9 and 21 EMAs and a short-term downtrend suggest timing is unfavorable now. A pullback toward the rising EMAs or the 50 DMA support region would present a higher-probability entry opportunity.

• ↑Q2 product revenue $57.4 M (+10% YoY); full-year 2026 guidance $229–231 M (+10–12%)
• ↑Operating expenses down 7% YoY; adjusted EBITDA more than tripled
• ↓Operating cash flow –$2.7 M raises near-term liquidity concerns